Related by context. Frequent words. (Click for all words.) 62 Vacation Interval sales 62 Operating Expenses Operating 61 Ps.2 61 Non GAAP adjusted EBITDA 60 Segment EBIT 60 PTOI 60 adjusted EBITDAR 60 Noninterest expenses 60 Sequentially 60 Property NOI 58 BioMarin Genzyme LLC 58 1Q FY# 58 excluding divestments 58 Pretax Income 58 3Q FY# 58 GBP #.#m [003] 57 Order Backlog 57 pro forma adjusted EBITDA 57 ROAA 57 Gross Margins 57 quarterof 57 Engineered Films 57 bps sequentially 57 Q2 FY# [001] 57 Normalized FFO 57 Industrial Specialties 57 Normalized EBITDA 57 Novogyne 56 LIFO expense 56 noninterest expense 56 owned OREO 56 Including discontinued operations 56 Inland Barge Group 56 sequential improvement 56 Earned premiums 56 intangible impairment 56 2Q FY# [001] 55 Comparable store 55 Loan originations 55 per MCFE 55 EBITDAR margin 55 Gross profit 55 Noninterest 55 Interest Expenses 55 Subsea Products 55 Identical store 55 normalized FFO 55 Specialty Chemicals segment 55 noninterest expenses 54 EBIT amounted 54 Interest expense decreased 54 Adjusted EBIT 54 Harland Acquisition 54 EMEA APAC 54 Gross margins 54 Operating Margins 54 Total noninterest expense 54 Record Second Quarter 54 OREO properties 54 Gross margin 54 PLAVIX R 54 sequential basis 54 unfavorable variance 54 OTTI charges 54 AOCF 54 noninterest bearing deposits 54 Noninterest expense 54 gross margin 54 net chargeoffs 54 Order Bookings 53 Excluding nonrecurring items 53 Administrative SG 53 Owned Hotels 53 repossessed assets 53 MedSurg 53 unallocated corporate 53 Broadway Ticketing 53 Consolidated Adjusted EBITDA 53 noninterest income 53 early extinguishments 53 Lenovo AsiaInfo 53 Overall NewMarket 53 LIFO inventory valuation 53 Asset Turnover 53 Q#/# EUR [001] 53 thirdquarter 53 Flat Rolled Products 53 Fully diluted earnings 53 Pro Forma Adjusted EBITDA 52 duration mediaQueryString 52 Coming Biotech Boom 52 Total noninterest expenses 52 MBbls 52 seasonally weakest 52 H1 FY# [002] 52 excluding nonrecurring items 52 intersegment eliminations 52 - Operating [025] 52 Underlying EBIT 52 Revenues Increase 52 noninterest